InSilicoTrials Email Format
IT Services and IT ConsultingDelaware, United States11-50 Employees
InSilicoTrials offers an AI-powered platform that supports drug development by giving pharmaceutical and biotech firms access to a library of computational models to simulate drug interactions and forecast outcomes. The system uses digital patient twins and advanced AI to enable faster discovery and reduce reliance on early-stage human trials, improving decision-making throughout development. These features address the high costs and long timelines that characterize conventional drug development. The company is based in Wilmington, Delaware, and sits within the IT services and IT consulting industry, focusing on technology-enabled life sciences solutions. It operates as a small to mid-sized firm with a specialized emphasis on simulation and digital twin applications in pharma development. In 2024, InSilicoTrials received the AI Startup of the Year Award at Startup Grind Global, reflecting external recognition in its sector.